Vertex Pharmaceuticals Incorporated (VRTX)
USD 478.23
(-1.19%)
USD 478.23
(-1.19%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -9.56 Billion USD | 3.81% |
| 2022 | -9.94 Billion USD | -59.39% |
| 2021 | -6.23 Billion USD | -15.38% |
| 2020 | -5.4 Billion USD | -113.54% |
| 2019 | -2.53 Billion USD | -21.55% |
| 2018 | -2.08 Billion USD | -89.1% |
| 2017 | -1.1 Billion USD | -218.63% |
| 2016 | -345.69 Million USD | -426.6% |
| 2015 | 105.84 Million USD | -47.09% |
| 2014 | 200.03 Million USD | 255.84% |
| 2013 | -128.36 Million USD | -170.06% |
| 2012 | 183.22 Million USD | 343.26% |
| 2011 | -75.32 Million USD | -125.64% |
| 2010 | 293.79 Million USD | 200.33% |
| 2009 | -292.82 Million USD | -188.17% |
| 2008 | -101.61 Million USD | 69.73% |
| 2007 | -335.66 Million USD | -275.4% |
| 2006 | -89.41 Million USD | -187.62% |
| 2005 | 102.05 Million USD | -63.55% |
| 2004 | 279.99 Million USD | 13.25% |
| 2003 | 247.22 Million USD | 12.36% |
| 2002 | 220.04 Million USD | 58.99% |
| 2001 | 138.4 Million USD | 401.45% |
| 2000 | 27.6 Million USD | 213.11% |
| 1999 | -24.4 Million USD | -69.44% |
| 1998 | -14.4 Million USD | 77.18% |
| 1997 | -63.1 Million USD | -139.02% |
| 1996 | -26.4 Million USD | -23.36% |
| 1995 | -21.4 Million USD | 67.18% |
| 1994 | -65.2 Million USD | -188.5% |
| 1993 | -22.6 Million USD | -247.69% |
| 1992 | -6.5 Million USD | 73.25% |
| 1991 | -24.3 Million USD | -1925.0% |
| 1990 | -1.2 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -8.43 Billion USD | 11.79% |
| 2024 Q3 | -3.53 Billion USD | 3.03% |
| 2024 Q2 | -3.64 Billion USD | 56.78% |
| 2023 FY | -9.56 Billion USD | 3.81% |
| 2023 Q1 | -8.5 Billion USD | 14.51% |
| 2023 Q3 | -10.36 Billion USD | -10.47% |
| 2023 Q4 | -9.56 Billion USD | 7.73% |
| 2023 Q2 | -9.38 Billion USD | -10.39% |
| 2022 FY | -9.94 Billion USD | -59.39% |
| 2022 Q4 | -9.94 Billion USD | -14.43% |
| 2022 Q3 | -8.68 Billion USD | -6.35% |
| 2022 Q2 | -8.17 Billion USD | -15.8% |
| 2022 Q1 | -7.05 Billion USD | -13.11% |
| 2021 Q1 | -5.73 Billion USD | -6.01% |
| 2021 Q2 | -5.49 Billion USD | 4.14% |
| 2021 Q3 | -5.71 Billion USD | -4.06% |
| 2021 Q4 | -6.23 Billion USD | -9.12% |
| 2021 FY | -6.23 Billion USD | -15.38% |
| 2020 Q2 | -4.26 Billion USD | -41.33% |
| 2020 Q4 | -5.4 Billion USD | -13.34% |
| 2020 Q1 | -3.02 Billion USD | -19.3% |
| 2020 FY | -5.4 Billion USD | -113.54% |
| 2020 Q3 | -4.77 Billion USD | -11.75% |
| 2019 Q3 | -2.81 Billion USD | -4.18% |
| 2019 Q2 | -2.7 Billion USD | -17.77% |
| 2019 Q1 | -2.29 Billion USD | -10.31% |
| 2019 Q4 | -2.53 Billion USD | 10.19% |
| 2019 FY | -2.53 Billion USD | -21.55% |
| 2018 FY | -2.08 Billion USD | -89.1% |
| 2018 Q4 | -2.08 Billion USD | -8.91% |
| 2018 Q3 | -1.91 Billion USD | -21.41% |
| 2018 Q2 | -1.57 Billion USD | -10.28% |
| 2018 Q1 | -1.42 Billion USD | -29.68% |
| 2017 Q2 | -697.58 Million USD | -38.3% |
| 2017 Q3 | -837.42 Million USD | -20.05% |
| 2017 Q4 | -1.1 Billion USD | -31.53% |
| 2017 FY | -1.1 Billion USD | -218.63% |
| 2017 Q1 | -504.39 Million USD | -45.91% |
| 2016 Q1 | 220.69 Million USD | 108.51% |
| 2016 Q2 | 215.22 Million USD | -2.48% |
| 2016 Q3 | 96.05 Million USD | -55.37% |
| 2016 FY | -345.69 Million USD | -426.6% |
| 2016 Q4 | -345.69 Million USD | -459.91% |
| 2015 Q3 | 64.73 Million USD | 240.49% |
| 2015 Q2 | -46.07 Million USD | -127.26% |
| 2015 Q1 | 169.02 Million USD | -15.5% |
| 2015 Q4 | 105.84 Million USD | 63.51% |
| 2015 FY | 105.84 Million USD | -47.09% |
| 2014 Q2 | 52.71 Million USD | 6.88% |
| 2014 Q4 | 200.03 Million USD | 305.36% |
| 2014 Q1 | 49.31 Million USD | 138.42% |
| 2014 FY | 200.03 Million USD | 255.84% |
| 2014 Q3 | 49.34 Million USD | -6.38% |
| 2013 Q4 | -128.36 Million USD | 32.66% |
| 2013 Q1 | 337.72 Million USD | 84.32% |
| 2013 FY | -128.36 Million USD | -170.06% |
| 2013 Q2 | -172.14 Million USD | -150.97% |
| 2013 Q3 | -190.61 Million USD | -10.73% |
| 2012 Q1 | 132.07 Million USD | 275.35% |
| 2012 Q3 | -36.88 Million USD | 31.77% |
| 2012 Q4 | 183.22 Million USD | 596.73% |
| 2012 FY | 183.22 Million USD | 343.26% |
| 2012 Q2 | -54.06 Million USD | -140.93% |
| 2011 FY | -75.32 Million USD | -125.64% |
| 2011 Q4 | -75.32 Million USD | 47.16% |
| 2011 Q3 | -142.54 Million USD | -144.94% |
| 2011 Q2 | -58.19 Million USD | -25.05% |
| 2011 Q1 | -46.53 Million USD | -115.84% |
| 2010 Q3 | -169.9 Million USD | 32.36% |
| 2010 Q2 | -251.2 Million USD | 7.38% |
| 2010 Q1 | -271.23 Million USD | 7.37% |
| 2010 Q4 | 293.79 Million USD | 272.92% |
| 2010 FY | 293.79 Million USD | 200.33% |
| 2009 FY | -292.82 Million USD | -188.17% |
| 2009 Q1 | -314.69 Million USD | -209.7% |
| 2009 Q2 | -264.94 Million USD | 15.81% |
| 2009 Q3 | -415.13 Million USD | -56.68% |
| 2009 Q4 | -292.82 Million USD | 29.46% |
| 2008 Q3 | -255.37 Million USD | 2.58% |
| 2008 Q4 | -101.61 Million USD | 60.21% |
| 2008 FY | -101.61 Million USD | 69.73% |
| 2008 Q1 | -203.19 Million USD | 39.46% |
| 2008 Q2 | -262.13 Million USD | -29.0% |
| 2007 Q3 | -233.98 Million USD | -119.46% |
| 2007 FY | -335.66 Million USD | -275.4% |
| 2007 Q2 | -106.61 Million USD | 63.12% |
| 2007 Q1 | -289.1 Million USD | -223.32% |
| 2007 Q4 | -335.66 Million USD | -43.46% |
| 2006 FY | -89.41 Million USD | -187.62% |
| 2006 Q4 | -89.41 Million USD | 76.57% |
| 2006 Q2 | 138.66 Million USD | 41.1% |
| 2006 Q1 | 98.27 Million USD | -3.71% |
| 2006 Q3 | -381.68 Million USD | -375.26% |
| 2005 Q4 | 102.05 Million USD | -47.1% |
| 2005 FY | 102.05 Million USD | -63.55% |
| 2005 Q1 | 297.62 Million USD | 6.3% |
| 2005 Q2 | 140.3 Million USD | -52.86% |
| 2005 Q3 | 192.92 Million USD | 37.51% |
| 2004 FY | 279.99 Million USD | 13.25% |
| 2004 Q2 | 258.92 Million USD | -1.19% |
| 2004 Q1 | 262.02 Million USD | 5.99% |
| 2004 Q3 | 282.65 Million USD | 9.16% |
| 2004 Q4 | 279.99 Million USD | -0.94% |
| 2003 Q1 | 149.12 Million USD | -32.23% |
| 2003 FY | 247.22 Million USD | 12.36% |
| 2003 Q2 | 207.36 Million USD | 39.06% |
| 2003 Q3 | 267.88 Million USD | 29.18% |
| 2003 Q4 | 247.22 Million USD | -7.71% |
| 2002 Q4 | 220.04 Million USD | -0.29% |
| 2002 FY | 220.04 Million USD | 58.99% |
| 2002 Q3 | 220.68 Million USD | 10.35% |
| 2002 Q2 | 199.98 Million USD | 33.29% |
| 2002 Q1 | 150.03 Million USD | 8.4% |
| 2001 Q4 | 138.4 Million USD | -14.99% |
| 2001 Q3 | 162.79 Million USD | -9.62% |
| 2001 Q2 | 180.12 Million USD | 42.4% |
| 2001 Q1 | 126.49 Million USD | 358.3% |
| 2001 FY | 138.4 Million USD | 401.45% |
| 2000 FY | 27.6 Million USD | 213.11% |
| 2000 Q1 | -10.32 Million USD | 57.69% |
| 2000 Q2 | -2.38 Million USD | 76.9% |
| 2000 Q3 | 40.49 Million USD | 1797.78% |
| 2000 Q4 | 27.6 Million USD | -31.84% |
| 1999 Q2 | -2.8 Million USD | 73.83% |
| 1999 FY | -24.4 Million USD | -69.44% |
| 1999 Q4 | -24.4 Million USD | -67.12% |
| 1999 Q1 | -10.7 Million USD | 25.69% |
| 1999 Q3 | -14.6 Million USD | -421.43% |
| 1998 Q4 | -14.4 Million USD | 63.36% |
| 1998 FY | -14.4 Million USD | 77.18% |
| 1998 Q1 | -49.7 Million USD | 21.24% |
| 1998 Q2 | -26.7 Million USD | 46.28% |
| 1998 Q3 | -39.3 Million USD | -47.19% |
| 1997 Q2 | -180.4 Million USD | -134.9% |
| 1997 Q3 | -169 Million USD | 6.32% |
| 1997 Q1 | -76.8 Million USD | -190.91% |
| 1997 Q4 | -63.1 Million USD | 62.66% |
| 1997 FY | -63.1 Million USD | -139.02% |
| 1996 FY | -26.4 Million USD | -23.36% |
| 1996 Q4 | -26.4 Million USD | 18.01% |
| 1996 Q1 | -13.7 Million USD | 35.98% |
| 1996 Q2 | -2.4 Million USD | 82.48% |
| 1996 Q3 | -32.2 Million USD | -1241.67% |
| 1995 Q4 | -21.4 Million USD | 34.36% |
| 1995 FY | -21.4 Million USD | 67.18% |
| 1995 Q1 | -44.8 Million USD | 31.29% |
| 1995 Q2 | -37.2 Million USD | 16.96% |
| 1995 Q3 | -32.6 Million USD | 12.37% |
| 1994 Q3 | -42.2 Million USD | -175.82% |
| 1994 Q2 | -15.3 Million USD | 68.65% |
| 1994 FY | -65.2 Million USD | -188.5% |
| 1994 Q1 | -48.8 Million USD | -115.93% |
| 1994 Q4 | -65.2 Million USD | -54.5% |
| 1993 FY | -22.6 Million USD | -247.69% |
| 1993 Q1 | -9.7 Million USD | -49.23% |
| 1993 Q2 | -600 Thousand USD | 93.81% |
| 1993 Q3 | -9.1 Million USD | -1416.67% |
| 1993 Q4 | -22.6 Million USD | -148.35% |
| 1992 Q2 | -11.9 Million USD | 43.87% |
| 1992 Q1 | -21.2 Million USD | 12.76% |
| 1992 Q3 | -17.7 Million USD | -48.74% |
| 1992 Q4 | -6.5 Million USD | 63.28% |
| 1992 FY | -6.5 Million USD | 73.25% |
| 1991 Q3 | -3.9 Million USD | -425.0% |
| 1991 FY | -24.3 Million USD | -1925.0% |
| 1991 Q2 | 1.2 Million USD | 0.0% |
| 1991 Q4 | -24.3 Million USD | -523.08% |
| 1990 FY | -1.2 Million USD | 0.0% |
| 1990 Q4 | -1.2 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -16996.711% |
| Alkermes plc | -166.73 Million USD | -5635.851% |
| Agenus Inc. | 274.13 Million USD | 3588.743% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 611.455% |
| Aptorum Group Limited | 1.35 Million USD | 704858.719% |
| Ardelyx, Inc. | 34.51 Million USD | 27811.81% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 223555.607% |
| Bicycle Therapeutics plc | -481.46 Million USD | -1886.408% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 26546.644% |
| ChromaDex Corporation | -24.04 Million USD | -39670.043% |
| Chimerix, Inc. | -25.51 Million USD | -37380.503% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 137353.095% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -40293.209% |
| CRISPR Therapeutics AG | -150.84 Million USD | -6240.217% |
| Precision BioSciences, Inc. | -85.41 Million USD | -11097.635% |
| Dyadic International, Inc. | -6.37 Million USD | -149849.068% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -59925.733% |
| Fortress Biotech, Inc. | 7.66 Million USD | 124873.646% |
| Lantern Pharma Inc. | -21.7 Million USD | -43966.615% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -8552.216% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -111847.828% |
| Incyte Corporation | -3.17 Billion USD | -201.217% |
| IO Biotech, Inc. | -140.69 Million USD | -6697.419% |
| Jaguar Health, Inc. | 29.39 Million USD | 32640.233% |
| Novavax, Inc. | -298.29 Million USD | -3106.199% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 179299.925% |
| Opthea Limited | 28.15 Million USD | 34065.795% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -56865.275% |
| ContextLogic Inc. | -232 Million USD | -4022.371% |
| MiMedx Group, Inc. | -33.9 Million USD | -28111.262% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 93909.711% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -412666.014% |
| NextCure, Inc. | -6.47 Million USD | -147559.41% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -18838.041% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -149827.888% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 78729.368% |
| Vaxcyte, Inc. | -368.22 Million USD | -2497.284% |
| PDS Biotechnology Corporation | -32.7 Million USD | -29139.442% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 55453.05% |
| Pharming Group N.V. | 109.8 Million USD | 8809.974% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -54877.581% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -5357.912% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -51541.33% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -51541.33% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -134602.817% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -163106.485% |
| Acelyrin, Inc. | -216.9 Million USD | -4309.298% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -170371.388% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -554650.58% |
| Summit Therapeutics Inc. | 34.67 Million USD | 27682.338% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -140483.566% |
| Senti Biosciences, Inc. | 1.74 Million USD | 549749.425% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -5080.681% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -12248.323% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -157668.063% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 9586143.761% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 1523014.013% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -8071.061% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -5584.913% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 8726.229% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -125807.056% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -7307.33% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 138815.847% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -3846.106% |
| Immix Biopharma, Inc. | -17.5 Million USD | -54520.298% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -2919.832% |
| MEI Pharma, Inc. | -3.7 Million USD | -258034.953% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 76543.929% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 6013.059% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 34511.183% |
| Fortress Biotech, Inc. | 7.66 Million USD | 124873.646% |
| Precigen, Inc. | -481 Thousand USD | -1988236.798% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 68020.602% |
| AlloVir, Inc. | -62.69 Million USD | -15155.375% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -17096.929% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 15609.195% |
| ImmuCell Corporation | 10.99 Million USD | 87119.208% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -6104.443% |
| Onconetix, Inc. | 5.33 Million USD | 179486.908% |
| PureTech Health plc | -167.19 Million USD | -5620.139% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -31298.227% |
| Elevation Oncology, Inc. | -19.11 Million USD | -49925.63% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -194723.793% |
| Seer, Inc. | -4.24 Million USD | -225463.679% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -39688.243% |
| Innoviva, Inc. | 255.56 Million USD | 3842.287% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -17019.97% |
| ESSA Pharma Inc. | -33.62 Million USD | -28345.715% |
| GlycoMimetics, Inc. | -40.98 Million USD | -23235.448% |
| GT Biopharma, Inc. | -1.02 Million USD | -936618.903% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -14009.585% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 15712.746% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -7033.034% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -68923.528% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -33025.173% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -12695230.13% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -30889.242% |
| Aptose Biosciences Inc. | -8.19 Million USD | -116606.124% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -305551.805% |
| Soligenix, Inc. | -4.95 Million USD | -193047.786% |
| Century Therapeutics, Inc. | 847 Thousand USD | 1129249.941% |
| Kura Oncology, Inc. | -20.11 Million USD | -47439.02% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -23268.763% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -113783.067% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 525100.069% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -299052.33% |
| Autolus Therapeutics plc | -186.59 Million USD | -5025.376% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -19297.818% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -3367.769% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 28009.128% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 5918.59% |
| GRI Bio, Inc. | -1.79 Million USD | -533004.794% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -106366.114% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -28657.555% |
| IGM Biosciences, Inc. | -72.6 Million USD | -13072.327% |
| INmune Bio, Inc. | -25.41 Million USD | -37536.85% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 6435.765% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -18778.972% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -58757.044% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -331412.836% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 25258.227% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -23121.804% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 30094.982% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 2630.46% |
| Verastem, Inc. | -37.27 Million USD | -25555.615% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -105310.559% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -18341.055% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -63090.618% |
| Histogen Inc. | -7.48 Million USD | -127640.083% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -44163.339% |
| Surrozen, Inc. | -32.66 Million USD | -29179.635% |
| Organovo Holdings, Inc. | -1.5 Million USD | -634531.719% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -227422.952% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 50541.957% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 365692.508% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 230222.714% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -114012.025% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -21915.331% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -65510.152% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -2919.013% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -1324429.817% |
| Apollomics, Inc. | -27.39 Million USD | -34811.115% |
| Amarin Corporation plc | -191.04 Million USD | -4906.229% |
| Mesoblast Limited | 55.96 Million USD | 17189.684% |
| Turnstone Biologics Corp. | -14.58 Million USD | -65478.031% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -37713.933% |
| Synaptogenix, Inc. | -28.66 Million USD | -33268.458% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -1021684.188% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 19725.503% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -1109286.618% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -131523.929% |
| Exelixis, Inc. | -73.05 Million USD | -12992.266% |
| Better Therapeutics, Inc. | -860 Thousand USD | -1111981.395% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -39728.01% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -3862.324% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 1299426.419% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -128479.274% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 762771.451% |
| Gritstone bio, Inc. | 39.49 Million USD | 24318.536% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -11271.922% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -363250.734% |
| Avid Bioservices, Inc. | 169.72 Million USD | 5734.839% |
| Insmed Incorporated | 721.62 Million USD | 1425.337% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -104520.549% |
| MediWound Ltd. | -5.32 Million USD | -179604.998% |
| OmniAb, Inc. | 9.2 Million USD | 104021.547% |
| Alector, Inc. | -35.63 Million USD | -26736.995% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 11224.565% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -193972.646% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 72340.35% |
| Zai Lab Limited | -775 Million USD | -1134.052% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 2908.328% |
| Aura Biosciences, Inc. | -21.52 Million USD | -44331.591% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -11495.417% |
| Immunic, Inc. | -45.34 Million USD | -20993.736% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -4849.874% |
| Veracyte, Inc. | -203.82 Million USD | -4592.234% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 1598.355% |
| FibroGen, Inc. | 56.76 Million USD | 16947.64% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 107499.214% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -338195.812% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -461846.494% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 308.348% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -286158.605% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -5662.635% |
| TG Therapeutics, Inc. | 17.86 Million USD | 53643.276% |
| Galecto, Inc. | -21.21 Million USD | -44978.714% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -40109.796% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 709.398% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -38980.991% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -83013.757% |
| XBiotech Inc. | -200.02 Million USD | -4681.4% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -11271.922% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 211316.873% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -27021.629% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -12285.584% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 168153.066% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -5512.123% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -10253.454% |
| Vaxxinity, Inc. | 10.13 Million USD | 94493.012% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 1398.973% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -88721.497% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -14400.425% |
| NexImmune, Inc. | -3.13 Million USD | -305100.688% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -276899.878% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -63189.095% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -35191.144% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -106449.059% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -7677122.557% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -23472.661% |
| Ainos, Inc. | 4.07 Million USD | 234628.417% |
| Pluri Inc. | 22.82 Million USD | 41993.644% |
| Prothena Corporation plc | -608.34 Million USD | -1472.113% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -7953.404% |
| Celularity Inc. | 65.19 Million USD | 14770.808% |
| Rallybio Corporation | -24.1 Million USD | -39580.939% |
| Cue Biopharma, Inc. | -33.81 Million USD | -28179.665% |
| MeiraGTx Holdings plc | -40.3 Million USD | -23630.584% |
| Omeros Corporation | 331.17 Million USD | 2987.86% |
| Humacyte, Inc. | -22.48 Million USD | -42432.687% |
| Immunocore Holdings plc | -358.59 Million USD | -2567.055% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -38817.192% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -30850.131% |
| Blueprint Medicines Corporation | 702.83 Million USD | 1460.758% |
| CalciMedica, Inc. | -5.53 Million USD | -172845.75% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -4981.235% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -93535.207% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -23787.654% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -28661.014% |
| Pulmatrix, Inc. | -10.41 Million USD | -91710.502% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -159911.712% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -24974.459% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -8485.034% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -15854.721% |
| Cytokinetics, Incorporated | 642.37 Million USD | 1588.841% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -164143.517% |
| Nutriband Inc. | -251.65 Thousand USD | -3800271.14% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -27931.009% |
| Vor Biopharma Inc. | 4.3 Million USD | 222516.279% |
| Roivant Sciences Ltd. | -6.03 Billion USD | -58.449% |
| Evogene Ltd. | -19.63 Million USD | -48610.91% |
| ProKidney Corp. | -56.23 Million USD | -16906.722% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -19549.696% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -103436.932% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 801.216% |
| CorMedix Inc. | -43.05 Million USD | -22114.503% |
| BioLineRx Ltd. | 7.33 Million USD | 130469.411% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -34722.137% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 20824.858% |
| Atai Life Sciences N.V. | -28.55 Million USD | -33389.39% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 428872.726% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -41817.514% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 54026.699% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -12639.297% |
| MediciNova, Inc. | -50.78 Million USD | -18732.686% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -12036.159% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -42515570.149% |
| GeoVax Labs, Inc. | -6.45 Million USD | -148118.025% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -4686.234% |
| Biomea Fusion, Inc. | -166.57 Million USD | -5641.67% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -5243.707% |
| Mereo BioPharma Group plc | -51.46 Million USD | -18481.865% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -9983.822% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -3155.696% |
| Absci Corporation | -72.59 Million USD | -13073.779% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 209559.045% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -3979.518% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -10051.575% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -9894.044% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -24377.005% |
| Allakos Inc. | -24.97 Million USD | -38193.894% |
| Imunon, Inc. | -4.21 Million USD | -226863.358% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -64775.187% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -6963.442% |
| BioAtla, Inc. | -109.01 Million USD | -8673.335% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 1299426.419% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -1018419.702% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 80025.623% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -45006.353% |
| XOMA Corporation | -29 Million USD | -32878.966% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -57653.019% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -105976.974% |
| aTyr Pharma, Inc. | -7.44 Million USD | -128291.73% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -7573.465% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -4494.406% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -11594.812% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -10210.037% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -1113037.582% |
| Akari Therapeutics, Plc | -3.84 Million USD | -248636.021% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 589412.892% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 792.596% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -804850.616% |
| UroGen Pharma Ltd. | 4.39 Million USD | 217906.878% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 8527.754% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 13290308.721% |
| Orgenesis Inc. | 21.78 Million USD | 44003.324% |
| Entera Bio Ltd. | -10.62 Million USD | -89879.302% |
| GH Research PLC | -78.07 Million USD | -12149.318% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -42810.535% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -35774.939% |
| Xencor, Inc. | 29.64 Million USD | 32362.515% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -485423.492% |
| Replimune Group, Inc. | 1.41 Million USD | 677430.028% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -3904999.058% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -7465.359% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -804850.616% |
| Portage Biotech Inc. | -4.98 Million USD | -191907.629% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -42515570.149% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -14364.021% |
| OncoCyte Corporation | -6.56 Million USD | -145624.516% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 1065818.905% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -209835.239% |
| Purple Biotech Ltd. | -14.13 Million USD | -67546.768% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -40158.882% |
| scPharmaceuticals Inc. | -6.54 Million USD | -146025.286% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -57195.743% |
| HilleVax, Inc. | -165.48 Million USD | -5679.315% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -376728.211% |
| Tharimmune, Inc. | -10.93 Million USD | -87358.547% |
| Genprex, Inc. | -6.73 Million USD | -141847.56% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | -2493.199% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -10711.553% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -682548.108% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -288234.51% |
| OKYO Pharma Limited | -826.84 Thousand USD | -1156569.666% |
| Savara Inc. | 153 Thousand USD | 6251015.033% |
| Curis, Inc. | -23.88 Million USD | -39938.096% |
| Daré Bioscience, Inc. | -5.15 Million USD | -185321.966% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -1232342.282% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -153957.668% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 807180.169% |
| BeiGene, Ltd. | -2.25 Billion USD | -324.48% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 77612.664% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | -1472.482% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -5053.352% |
| Erasca, Inc. | -37.21 Million USD | -25598.356% |
| bluebird bio, Inc. | 108.57 Million USD | 8908.89% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -742500.511% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 2625.135% |
| DBV Technologies S.A. | -126.98 Million USD | -7431.46% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -742500.511% |
| Moderna, Inc. | -2.9 Billion USD | -228.996% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -92286.978% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -87900.552% |
| Molecular Templates, Inc. | 707 Thousand USD | 1352843.989% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -30386.437% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 2859.284% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -11554.481% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -10326.142% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -29535.288% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -27721.445% |
| MacroGenics, Inc. | -66.98 Million USD | -14177.674% |
| RenovoRx, Inc. | -1.17 Million USD | -815236.743% |
| Adicet Bio, Inc. | -138.78 Million USD | -6791.063% |
| Prime Medicine, Inc. | -27.94 Million USD | -34128.911% |
| Aditxt, Inc. | 18.12 Million USD | 52878.327% |
| Adagene Inc. | -87.62 Million USD | -10814.282% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -229501.856% |
| Quantum-Si incorporated | -118.55 Million USD | -7966.921% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 26662.7% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -127859.051% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -19615.723% |
| SciSparc Ltd. | -2.06 Million USD | -463042.857% |
| Vericel Corporation | 1.27 Million USD | 749035.004% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -79654.323% |
| Minerva Neurosciences, Inc. | 41 Million USD | 23424.169% |
| Generation Bio Co. | 31.44 Million USD | 30511.791% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -5353.742% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -30828.112% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 8302.808% |
| Invivyd, Inc. | -198.47 Million USD | -4718.668% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -10494.771% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -398780.043% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -13410.242% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -140030.403% |
| 2seventy bio, Inc. | 181.71 Million USD | 5363.132% |
| ADMA Biologics, Inc. | 90.06 Million USD | 10718.768% |
| Clene Inc. | 3.34 Million USD | 286444.311% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -105197.949% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -44360.509% |
| GeoVax Labs, Inc. | -6.45 Million USD | -148118.025% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -2679.202% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -36684.679% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 5483.078% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -233646.631% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 191301.519% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -183503.379% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -7239.683% |
| Evaxion Biotech A/S | 5.28 Million USD | 180999.985% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -8396.109% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -7185.504% |
| Trevena, Inc. | 2.25 Million USD | 423656.244% |
| Surrozen, Inc. | -32.66 Million USD | -29179.635% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -18467.074% |
| Cingulate Inc. | 3.08 Million USD | 310345.977% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -325535.002% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 133172.214% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -102834.736% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -11956.907% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -7175.583% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -8961.701% |
| Clearmind Medicine Inc. | -3.94 Million USD | -242476.225% |
| Kronos Bio, Inc. | -36.05 Million USD | -26426.6% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 101746.296% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 656003.087% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -17527.359% |
| Statera Biopharma, Inc. | 14.41 Million USD | 66440.39% |
| ImmunityBio, Inc. | 618.22 Million USD | 1646.996% |
| Korro Bio, Inc. | -132.94 Million USD | -7093.985% |
| Kineta, Inc. | -4.54 Million USD | -210512.2% |
| BioVie Inc. | -17.73 Million USD | -53834.755% |
| Codexis, Inc. | -43.27 Million USD | -22002.332% |
| Celularity Inc. | 65.19 Million USD | 14770.808% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -301695.519% |
| Celcuity Inc. | 6.78 Million USD | 141087.504% |
| Virax Biolabs Group Limited | -3.36 Million USD | -284121.669% |
| Cibus, Inc. | -8.07 Million USD | -118294.405% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -226050.39% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 209375.711% |
| IN8bio, Inc. | -16.38 Million USD | -58255.604% |
| Kodiak Sciences Inc. | -103.87 Million USD | -9107.124% |
| Annexon, Inc. | -193.75 Million USD | -4836.079% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 26566488.889% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -54553.98% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -272143.097% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 1007.156% |
| Eyenovia, Inc. | 1.25 Million USD | 759922.42% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 35646.924% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -294809.035% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -28666.204% |
| Arcellx, Inc. | -296.95 Million USD | -3120.624% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -48930.555% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -16144.416% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -46042.23% |
| Moolec Science SA | 117.61 Thousand USD | 8131561.706% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -24806.638% |
| Geron Corporation | 14.76 Million USD | 64891.681% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -25122.586% |
| Royalty Pharma plc | 5.65 Billion USD | 269.025% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -6662.716% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -136733.879% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -178235.847% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -6695.873% |
| Humacyte, Inc. | -22.48 Million USD | -42432.687% |
| Structure Therapeutics Inc. | -124.33 Million USD | -7591.793% |
| 89bio, Inc. | -289.05 Million USD | -3208.701% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -37788.836% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -536293.718% |
| Genelux Corporation | -6.89 Million USD | -138527.337% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -30692.685% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 11540.209% |
| Notable Labs, Ltd. | -9.77 Million USD | -97730.401% |
| Liquidia Corporation | -80.17 Million USD | -11828.632% |
| Mustang Bio, Inc. | -3.73 Million USD | -255893.041% |
| Immunovant, Inc. | -635.22 Million USD | -1405.588% |
| Quantum-Si incorporated | -118.55 Million USD | -7966.921% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -54351.719% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -230744.798% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 119246.63% |
| Acasti Pharma Inc. | -23 Million USD | -41473.136% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -283928.796% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -58757.044% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -6843.444% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -306793.102% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -42918.622% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -51404.658% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -5549.819% |
| PepGen Inc. | -60.67 Million USD | -15663.804% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -41525.609% |
| United Therapeutics Corporation | -507.7 Million USD | -1783.77% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -49904.706% |
| Solid Biosciences Inc. | -47.75 Million USD | -19929.11% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -1109286.618% |
| Immuneering Corporation | -54.94 Million USD | -17306.994% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -227422.952% |
| Silo Pharma, Inc. | -3.52 Million USD | -271269.585% |
| Belite Bio, Inc | -87.27 Million USD | -10858.852% |
| XOMA Corporation | -29 Million USD | -32878.966% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -13428.014% |
| Bionomics Limited | 227 Million USD | 4312.988% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -8124.747% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -377472.049% |
| uniQure N.V. | -102.95 Million USD | -9189.759% |
| Cassava Sciences, Inc. | -121.13 Million USD | -7795.176% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -229501.856% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 23454.497% |
| Forte Biosciences, Inc. | -11.96 Million USD | -79859.034% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -308991.203% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 9022647.17% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -294809.035% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 107499.214% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -128863.053% |
| Altimmune, Inc. | -134.48 Million USD | -7011.394% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 4928.667% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -377472.049% |
| Compugen Ltd. | -12.9 Million USD | -74015.778% |
| Peak Bio, Inc. | 10.34 Million USD | 92592.784% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -3379369.965% |
| Benitec Biopharma Inc. | -50.58 Million USD | -18807.714% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -9066.267% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 48783.635% |
| Zura Bio Limited | -99.8 Million USD | -9482.49% |
| PolyPid Ltd. | 6.17 Million USD | 155106.483% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 13003.265% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 48783.635% |
| Instil Bio, Inc. | 75.35 Million USD | 12791.287% |
| argenx SE | -2.02 Billion USD | -371.397% |
| Immunome, Inc. | -97.02 Million USD | -9756.744% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -42415.67% |
| Verona Pharma plc | -220.44 Million USD | -4238.491% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -13230.778% |
| Shattuck Labs, Inc. | -121.42 Million USD | -7776.449% |
| CervoMed Inc. | -7.79 Million USD | -122626.665% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -5055.769% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -218603.407% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -7159.678% |
| Moolec Science SA | 117.61 Thousand USD | 8131561.706% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -417906.824% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 60256.444% |
| AnaptysBio, Inc. | -18.15 Million USD | -52590.761% |
| Design Therapeutics, Inc. | -18.15 Million USD | -52593.664% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -13488.753% |
| NeurAxis, Inc. | 145.7 Thousand USD | 6564204.324% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 85248.682% |
| Lumos Pharma, Inc. | -28.49 Million USD | -33465.788% |
| Achilles Therapeutics plc | -126.92 Million USD | -7435.139% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -13230.778% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -1458411.888% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -45938.224% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 656003.087% |
| Nutriband Inc. | -251.65 Thousand USD | -3800271.14% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -72513.317% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -128447.043% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 2911.283% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 40394.502% |
| MoonLake Immunotherapeutics | -447.47 Million USD | -2037.321% |
| Palisade Bio, Inc. | -12.06 Million USD | -79182.931% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -6716.215% |
| Beam Therapeutics Inc. | -262.72 Million USD | -3540.312% |
| Neurogene Inc. | -131.95 Million USD | -7147.85% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 43938.926% |
| AEON Biopharma, Inc. | -4.88 Million USD | -195881.557% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | -2435.559% |
| Sesen Bio, Inc. | -112.55 Million USD | -8397.241% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -9477.308% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -407257.037% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -24406.483% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -11383.754% |
| Athira Pharma, Inc. | -88.99 Million USD | -10646.076% |
| Vaccinex, Inc. | -1.28 Million USD | -742438.82% |
| HCW Biologics Inc. | 2.85 Million USD | 334891.205% |
| XOMA Corporation | -29 Million USD | -32878.966% |
| Nektar Therapeutics | 210.24 Million USD | 4649.039% |
| Arvinas, Inc. | -313.8 Million USD | -2947.769% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 589412.892% |
| Merus N.V. | -192.88 Million USD | -4858.369% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 16043.819% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -137748.083% |
| Rezolute, Inc. | -68.16 Million USD | -13929.897% |
| Clene Inc. | 3.34 Million USD | 286444.311% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -72425.214% |
| BeyondSpring Inc. | -13.75 Million USD | -69430.353% |
| Synlogic, Inc. | -6.68 Million USD | -142965.071% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 843477.425% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -113015.316% |
| Peak Bio, Inc. | 10.34 Million USD | 92592.784% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -11503.858% |
| Krystal Biotech, Inc. | -350.23 Million USD | -2630.717% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 7805.055% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -5559.246% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -302828.85% |
| MannKind Corporation | 143.89 Million USD | 6746.259% |
| Ikena Oncology, Inc. | -109.15 Million USD | -8661.681% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -126222.811% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -28793.958% |
| Gossamer Bio, Inc. | 180.35 Million USD | 5402.819% |
| CohBar, Inc. | -5.93 Million USD | -161160.054% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -32049.724% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 209559.045% |
| Legend Biotech Corporation | -949.39 Million USD | -907.365% |
| Mural Oncology plc | -255.84 Million USD | -3638.191% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 29787.723% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -202927.528% |
| Disc Medicine, Inc. | -358.28 Million USD | -2569.385% |
| Champions Oncology, Inc. | 4.81 Million USD | 198851.039% |
| REGENXBIO Inc. | 54.76 Million USD | 17562.569% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -3556482.759% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -6232.702% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -106023.986% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -11753.674% |
| Vaxart, Inc. | -8.24 Million USD | -115952.664% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -18959.199% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -7420.82% |
| Cellectis S.A. | -43.85 Million USD | -21708.004% |
| Longeveron Inc. | -2.9 Million USD | -328782.393% |
| Repare Therapeutics Inc. | -107.85 Million USD | -8767.122% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 1087.621% |
| Inozyme Pharma, Inc. | 12 Million USD | 79772.609% |
| Revolution Medicines, Inc. | -608.2 Million USD | -1472.482% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -777452.846% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -3507.426% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -6272.874% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -61022.899% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -1292318.919% |
| Denali Therapeutics Inc. | -74.86 Million USD | -12674.861% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -79654.323% |
| Veru Inc. | 4.77 Million USD | 200182.888% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -84942.682% |
| Cingulate Inc. | 3.08 Million USD | 310345.977% |
| Passage Bio, Inc. | 4.58 Million USD | 208691.058% |
| Context Therapeutics Inc. | -14.44 Million USD | -66086.952% |
| Exicure, Inc. | 5.84 Million USD | 163613.421% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -4051.431% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -24069.573% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 61051.501% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -16159.329% |
| Nuvalent, Inc. | -335.38 Million USD | -2751.601% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 551542.882% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -12740.552% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -107480.427% |
| OmniAb, Inc. | 9.2 Million USD | 104021.547% |
| Anew Medical, Inc. | 1.43 Million USD | 667753.311% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 58481.413% |
| Lipocine Inc. | -4.75 Million USD | -201050.803% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -8608.071% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 62892.331% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -18778.972% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 38521.581% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -142198.765% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -14428.841% |
| Ocugen, Inc. | -32.52 Million USD | -29308.382% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -11076.044% |
| Q32 Bio Inc. | -37.94 Million USD | -25102.646% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -1522814.013% |
| Alumis Inc. Common Stock | -13.52 Million USD | -70591.847% |
| Equillium, Inc. | -22.39 Million USD | -42611.236% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -37305.742% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -29213.047% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -3857633.497% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 7235.002% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 299158.787% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 2912008.075% |
| Dominari Holdings Inc. | 195 Thousand USD | 4904664.103% |
| Edesa Biotech, Inc. | -5.26 Million USD | -181484.648% |
| vTv Therapeutics Inc. | -8.91 Million USD | -107154.682% |
| Bio-Techne Corporation | 267.74 Million USD | 3671.991% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -58903.64% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -7998.549% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -113715.304% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -75497.976% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -3801.738% |
| Nkarta, Inc. | 57.29 Million USD | 16791.216% |
| BioCardia, Inc. | 212 Thousand USD | 4511373.585% |
| Iterum Therapeutics plc | 13.43 Million USD | 71270.561% |